Matthew Pauls - Director at Pelthos Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Issuer Symbol
PTHS on NYSE
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Matthew Pauls since 10 Feb 2025

Holdings reported by Matthew Pauls for Pelthos Therapeutics Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1,074 $30,609 $28.50 10 Dec 2025 Direct
Stock Option 77,640 02 Jul 2025 Direct Common Stock
Restricted Stock Units 14,862 02 Oct 2025 Direct Common Stock

Transactions reported by Matthew Pauls for Pelthos Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.